Jill Fallows Macaluso Esq., RN, has been Corporate Vice President and Chief Compliance Officer for Novo Nordisk Inc. since January 2018 and has been leading the US Compliance Program since being appointed Vice President and Chief Compliance Officer in September 2015. Ms. Fallows Macaluso is responsible for safeguarding corporate governance and integrity practices in the United States while upholding the company's commitment to operate according to the highest ethical standards of business conduct as part of the Novo Nordisk Way.
With 15 years of industry experience, Ms. Fallows Macaluso has been instrumental in evolving Novo Nordisk's compliance program to support industry leading business practices. By serving as a corporate compliance partner, she has spearheaded efforts focused on rebranding and operational efficiency. As chair of the Executive Ethics & Compliance Committee, she plays an active role ensuring compliance is incorporated into company decision-making processes.
Ms. Fallows Macaluso joined Novo Nordisk in 2003 and held several positions of escalating responsibility with in the Legal Team for nine years including Senior Corporate Counsel. She transitioned to the Compliance Department as Senior Director in 2012.
Previously, Ms. Fallows Macaluso was with the General Corporate and Healthcare practice of Day Pitney, LLP. She holds a Bachelor of Science in Nursing from the University of Pennsylvania and a Juris Doctorate from Rutgers University School of Law.